[1]
V. Gupta and P. Singh, “A short term evaluation of effect on serum urea, creatinine and potassium levels with use of angiotensin II receptor blockers (olmesartan or telmisartan) in stage 1 hypertensive patients”, Int J Basic Clin Pharmacol, vol. 8, no. 10, pp. 2328–2333, Sep. 2019.